Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 288
8
Diseases
91
Unique genes
0.218
Avg. similarity score
Heritable pulmonary arterial hypertension
Most-connected disease (6 links)
Disease
Searched: Heritable pulmonary arterial hypertension
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Heritable pulmonary arterial hypertension
Idiopathic pulmonary arterial hypertension
Pulmonary arterial hypertension
Pulmonary capillary hemangiomatosis
Pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis
Pulmonary venoocclusive disease 2
Pulmonary hypertension
Pulmonary hypertension, primary, autosomal recessive
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Heritable pulmonary arterial hypertension | 6 | 6 | 8 |
| Idiopathic pulmonary arterial hypertension | 5 | 5 | 3 |
| Pulmonary arterial hypertension | 4 | 4 | 45 |
| Pulmonary capillary hemangiomatosis | 4 | 4 | 1 |
| Pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis | 4 | 4 | 1 |
| Pulmonary venoocclusive disease 2 | 4 | 4 | 1 |
| Pulmonary hypertension | 3 | 3 | 62 |
| Pulmonary hypertension, primary, autosomal recessive | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| EIF2AK4 | 7 / 8 | Heritable pulmonary arterial hypertension, Idiopathic pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary capillary hemangiomatosis and 3 more |
| BMPR2 | 4 / 8 | Heritable pulmonary arterial hypertension, Idiopathic pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary hypertension |
| SMAD9 | 4 / 8 | Heritable pulmonary arterial hypertension, Idiopathic pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary hypertension |
| ACVRL1 | 3 / 8 | Heritable pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary hypertension |
| ATP13A3 | 3 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension, Pulmonary hypertension, primary, autosomal recessive |
| CAV1 | 3 / 8 | Heritable pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary hypertension |
| ENG | 3 / 8 | Heritable pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary hypertension |
| GDF2 | 3 / 8 | Heritable pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary hypertension |
| SOX17 | 3 / 8 | Heritable pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary hypertension |
| BMPR1B | 2 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension |
| CBLN2 | 2 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension |
| KCNA5 | 2 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension |
| KCNK3 | 2 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension |
| SMAD1 | 2 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension |
| SMAD4 | 2 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension |
| TBX4 | 2 / 8 | Pulmonary arterial hypertension, Pulmonary hypertension |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Signaling by BMP | Reactome | 9 / 28 | 42.4× | 3.37e-13 | 7.00e-11 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 10 / 141 | 9.4× | 1.03e-7 | 5.75e-6 ✓ sig. |
| TGF-beta signaling pathway | KEGG | 9 / 108 | 11.0× | 1.17e-7 | 6.40e-6 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 8 / 101 | 10.5× | 9.04e-7 | 3.82e-5 ✓ sig. |
| Notch-HLH transcription pathway | Reactome | 5 / 28 | 23.6× | 1.91e-6 | 7.29e-5 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 12 / 298 | 5.3× | 2.39e-6 | 8.78e-5 ✓ sig. |
| Allograft rejection | KEGG | 5 / 39 | 16.9× | 1.05e-5 | 3.03e-4 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 7 / 108 | 8.6× | 1.70e-5 | 4.56e-4 ✓ sig. |
| Hormone signaling | KEGG | 9 / 219 | 5.4× | 4.06e-5 | 9.25e-4 ✓ sig. |
| FOXO-mediated transcription of cell cycle genes | Reactome | 3 / 11 | 36.0× | 6.65e-5 | 1.37e-3 ✓ sig. |
| Apelin signaling pathway | KEGG | 7 / 140 | 6.6× | 9.01e-5 | 1.75e-3 ✓ sig. |
| Asthma | KEGG | 4 / 32 | 16.5× | 9.43e-5 | 1.81e-3 ✓ sig. |
| Calcium signaling pathway | KEGG | 9 / 254 | 4.7× | 1.27e-4 | 2.29e-3 ✓ sig. |
| Renin secretion | KEGG | 5 / 69 | 9.6× | 1.71e-4 | 2.91e-3 ✓ sig. |
| Th17 cell differentiation | KEGG | 6 / 109 | 7.3× | 1.74e-4 | 2.94e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| vasodilation | GO:0042311 | 11 / 50 | 45.2× | 6.26e-16 | 5.30e-13 ✓ sig. |
| angiogenesis | GO:0001525 | 16 / 284 | 11.6× | 4.98e-13 | 2.48e-10 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 19 / 504 | 7.7× | 3.31e-12 | 1.41e-9 ✓ sig. |
| BMP signaling pathway | GO:0030509 | 10 / 88 | 23.3× | 1.49e-11 | 5.48e-9 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 14 / 248 | 11.6× | 1.57e-11 | 5.73e-9 ✓ sig. |
| response to hypoxia | GO:0001666 | 12 / 176 | 14.0× | 5.53e-11 | 1.80e-8 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 26 / 1,208 | 4.4× | 6.29e-11 | 2.02e-8 ✓ sig. |
| lung development | GO:0030324 | 10 / 108 | 19.0× | 1.18e-10 | 3.57e-8 ✓ sig. |
| cellular response to BMP stimulus | GO:0071773 | 7 / 33 | 43.6× | 1.98e-10 | 5.64e-8 ✓ sig. |
| heart development | GO:0007507 | 13 / 273 | 9.8× | 7.21e-10 | 1.75e-7 ✓ sig. |
| positive regulation of SMAD protein signal transduction | GO:0060391 | 7 / 42 | 34.2× | 1.21e-9 | 2.73e-7 ✓ sig. |
| regulation of blood pressure | GO:0008217 | 8 / 83 | 19.8× | 6.77e-9 | 1.26e-6 ✓ sig. |
| cartilage development | GO:0051216 | 8 / 89 | 18.5× | 1.18e-8 | 2.04e-6 ✓ sig. |
| positive regulation of cartilage development | GO:0061036 | 5 / 17 | 60.4× | 1.45e-8 | 2.44e-6 ✓ sig. |
| vasoconstriction | GO:0042310 | 5 / 18 | 57.0× | 2.00e-8 | 3.22e-6 ✓ sig. |